Isotopia Molecular Imaging and Seibersdorf Labor GmbH Announce Production Agreement for 177Lu n.c.a.
Tel Aviv, Israel and Vienna, Austria (ots/PRNewswire) - Isotopia Molecular Imaging and Seibersdorf Labor are pleased to announce that they have entered into an agreement for the production of no-carrier-added Lutetium-177, a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for treatment of many types of cancer, including neuroendocrine tumors and prostate cancer.
Seibersdorf Labor, a GMP Contract manufacturing of radiopharmaceuticals, a global leader in the development, production and!-->…